{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T17:47:58Z","timestamp":1785779278329,"version":"3.56.0"},"reference-count":23,"publisher":"Georg Thieme Verlag KG","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Perinatol"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:p>\n            Objective\u2003The objective of this study was to compare the frequency and timing of laboratory abnormalities and evaluate optimal laboratory testing strategies in women with preeclampsia (PE) undergoing expectant management.<\/jats:p><jats:p>\n            Study Design\u2003Retrospective cohort study of women with inpatient expectant management of PE at \u226523 weeks at a tertiary center from 2015 to 2018 was conducted. Women ineligible for expectant management or with less than two laboratory sets (platelets, aspartate aminotransferase, and serum creatinine) before the decision to deliver were excluded. Women were categorized as per the American College of Obstetricians and Gynecologists' definitions by initial diagnosis: PE without severe features, superimposed preeclampsia (SiPE) without severe features, and their forms with severe features. The frequency and timing of laboratory abnormalities were compared across the four PE categories. Kaplan\u2013Meier curves modeled time to a laboratory abnormality (event) with censoring for delivery and were compared using log-rank tests. Logistic regression analysis modeled the development of a laboratory abnormality as a function of testing time intervals (days) for each PE type. Receiver operating characteristic curves and areas under the curve (AUC) were calculated; optimal cut points were determined using the Liu method.<\/jats:p><jats:p>\n            Results\u2003Among 636 women who met inclusion criteria, laboratory abnormalities were uncommon (6.3%). The median time to a laboratory abnormality among all women was \u226410 days, time being shortest in women with PE with severe features. Time to laboratory abnormality development did not differ significantly between the four PE groups (p\u2009=\u20090.36). Laboratory assessment intervals were most predictive for PE and SiPE with severe features (AUC\u2009=\u20090.87, AUC\u2009=\u20090.72). Optimal cutoffs were every 4 days for PE without severe features, 2 days for PE with severe features, 8 days for SiPE without severe features, and 3 days for SiPE with severe features.<\/jats:p><jats:p>\n            Conclusion\u2003Most laboratory abnormalities in PE occur earlier and more frequently in those with severe features. Individual phenotypes should undergo serial evaluation based on this risk stratification.<\/jats:p><jats:p>\n            Key Points\n          <\/jats:p>","DOI":"10.1055\/s-0041-1739511","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T23:52:56Z","timestamp":1637106776000},"page":"1704-1714","source":"Crossref","is-referenced-by-count":1,"title":["Defining a Strategy for Laboratory Evaluation with Expectant Management of Preeclampsia"],"prefix":"10.1055","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7164-9489","authenticated-orcid":false,"given":"Gabriella D.","family":"Cozzi","sequence":"additional","affiliation":[{"name":"Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, Alabama"},{"name":"Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina T.","family":"Blanchard","sequence":"additional","affiliation":[{"name":"Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, Alabama"},{"name":"Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aalok R.","family":"Sanjanwala","sequence":"additional","affiliation":[{"name":"Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, Alabama"},{"name":"Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret R.","family":"Page","sequence":"additional","affiliation":[{"name":"Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, Alabama"},{"name":"Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhong-Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, Alabama"},{"name":"Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan T.","family":"Tita","sequence":"additional","affiliation":[{"name":"Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, Alabama"},{"name":"Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff M.","family":"Szychowski","sequence":"additional","affiliation":[{"name":"Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, Alabama"},{"name":"Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akila","family":"Subramaniam","sequence":"additional","affiliation":[{"name":"Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, Alabama"},{"name":"Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2021,11,16]]},"reference":[{"issue":"14","key":"ref1","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1056\/NEJM199204023261405","article-title":"Hypertension in pregnancy","volume":"326","author":"F G Cunningham","year":"1992","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(00)03577-7","article-title":"Pathogenesis and genetics of pre-eclampsia","volume":"357","author":"J M Roberts","year":"2001","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"f6564","DOI":"10.1136\/bmj.f6564","article-title":"Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis","volume":"347","author":"C V Ananth","year":"2013","journal-title":"BMJ"},{"issue":"07","key":"ref4","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.annepidem.2004.12.008","article-title":"The risk of preeclampsia rises with increasing prepregnancy body mass index","volume":"15","author":"L M Bodnar","year":"2005","journal-title":"Ann Epidemiol"},{"issue":"05","key":"ref5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/jama.2012.39","article-title":"Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010","volume":"307","author":"K M Flegal","year":"2012","journal-title":"JAMA"},{"issue":"05","key":"ref6","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/ajh.2008.20","article-title":"Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004","volume":"21","author":"A B Wallis","year":"2008","journal-title":"Am J Hypertens"},{"issue":"02","key":"ref7","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/AOG.0000000000002114","article-title":"Pregnancy-related mortality in the United States, 2011-2013","volume":"130","author":"A A Creanga","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"06","key":"ref8","doi-asserted-by":"crossref","first-page":"514.e1","DOI":"10.1016\/j.ajog.2007.02.021","article-title":"Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications","volume":"196","author":"B M Sibai","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"02","key":"ref9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1081\/PRG-120021066","article-title":"Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States","volume":"22","author":"J Zhang","year":"2003","journal-title":"Hypertens Pregnancy"},{"issue":"05","key":"ref10","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.ahj.2008.06.042","article-title":"Cardiovascular sequelae of preeclampsia\/eclampsia: a systematic review and meta-analyses","volume":"156","author":"S D McDonald","year":"2008","journal-title":"Am Heart J"},{"issue":"01","key":"ref11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.semnephrol.2010.10.010","article-title":"Long-term complications of preeclampsia","volume":"31","author":"D Williams","year":"2011","journal-title":"Semin Nephrol"},{"issue":"01","key":"ref12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1067\/mob.2002.120080","article-title":"Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia","volume":"186","author":"A Buchbinder","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"05","key":"ref13","first-page":"1122","article-title":"Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' task force on hypertension in pregnancy","volume":"122","author":"American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"06","key":"ref14","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1097\/AOG.0000000000003892","article-title":"Gestational hypertension and preeclampsia: ACOG Practice Bulletin Summary, Number 222","volume":"135","author":"Gestational Hypertension and Preeclampsia","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"05","key":"ref15","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/AOG.0000000000000509","article-title":"Laboratory abnormalities in pregnancy-associated hypertension: frequency and association with pregnancy outcomes","volume":"124","author":"J Cantu","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"06","key":"ref16","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/jch.13302","article-title":"Risk factors for adverse maternal and perinatal outcomes in women with preeclampsia: analysis of 1396 cases","volume":"20","author":"X Li","year":"2018","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0002-9378(99)70026-8","article-title":"Early risk assessment of severe preeclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity","volume":"180","author":"J N Martin Jr","year":"1999","journal-title":"Am J Obstet Gynecol"},{"issue":"04","key":"ref18","first-page":"329","article-title":"The rising burden of preeclampsia in the United States impacts both maternal and child health","volume":"33","author":"T Shih","year":"2016","journal-title":"Am J Perinatol"},{"issue":"03","key":"ref19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ajog.2017.04.032","article-title":"Short-term costs of preeclampsia to the United States health care system","volume":"217","author":"W Stevens","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"23","key":"ref20","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1002\/sim.4509","article-title":"Classification accuracy and cut point\u2009selection","volume":"31","author":"X Liu","year":"2012","journal-title":"Stat Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(15)00070-7","article-title":"Pre-eclampsia","volume":"387","author":"B WJ Mol","year":"2016","journal-title":"Lancet"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/bs.apha.2016.04.008","article-title":"Mechanisms of endothelial dysfunction in hypertensive pregnancy and preeclampsia","volume":"77","author":"J S Possomato-Vieira","year":"2016","journal-title":"Adv Pharmacol"},{"issue":"02","key":"ref23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/HYPERTENSIONAHA.113.02293","article-title":"Angiogenic factors in diagnosis, management, and research in preeclampsia","volume":"63","author":"S Rana","year":"2014","journal-title":"Hypertension"}],"container-title":["American Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1739511.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T12:54:05Z","timestamp":1730811245000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0041-1739511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,16]]},"references-count":23,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2023,10,27]]},"published-print":{"date-parts":[[2023,11]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1739511","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0735-1631","1098-8785"],"issn-type":[{"value":"0735-1631","type":"print"},{"value":"1098-8785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,16]]}}}